Search results
Results from the WOW.Com Content Network
Lupin Limited is an Indian multinational pharmaceutical company based in Mumbai. It is one of the largest generic pharmaceutical companies by revenue globally. [ 10 ] The company's key focus areas include paediatrics , cardiovascular , anti-infectives , diabetology , asthma and anti-tuberculosis .
This listing is limited to those independent companies and subsidiaries notable enough to have their own articles in Wikipedia. Both going concerns and defunct firms are included, as well as firms that were part of the pharmaceutical industry at some time in their existence, provided they were engaged in the production of human (as opposed to veterinary) therapeutics.
Desh Bandhu Gupta (8 February 1938 – 26 June 2017) was an Indian billionaire, philanthropist, entrepreneur and the founder of Lupin Limited, a multinational pharmaceutical company. At the time of his death, his net worth was estimated at US$3.6 billion. [1]
The United Nations-backed Stop TB Partnership said J&J's new price of $130 and Lupin's price of $194 for a six-month course of the treatment represented a 55% and 33% price reduction, respectively.
In the same year, Kamboj was also appointed president of the Novel Drug Discovery and Development of Lupin Limited. [5] Dr Kamboj's experience includes contributions to business development, licensing products and technologies, mergers and acquisitions and corporate development activities.
The patent was scheduled to expire on 29 October 2008. On 11 September 2007, in an appeal by the Indian company Lupin Ltd., the United States Court of Appeals for the Federal Circuit reversed a district court trial verdict and found that Aventis's patent on ramipril was invalid for "obviousness", opening this drug to generic manufacturers.
Gupta joined Lupin in 1993, [3] and became CEO in 2013. Gupta was the chairman and CEO of Lupin Pharmaceuticals Inc, from 2003 to 2013, and grew the US business from 5% to over 45% of Lupin's total turnover. [2] The US is Lupin's largest market. [citation needed] Lupin's estimated annual cost savings to the US health system is approximately $15 ...
To become certified to prescribe buprenorphine, doctors have to first complete a one-day training class on addiction medicine. Then, for the first year of prescribing buprenorphine, certified doctors are limited to accepting only 30 patients with opioid addiction at any one time. They can move up to 100 patients in their second year of prescribing.